Alambic Investment Management’s Meridian Bioscience Inc VIVO Stock Holding History

Alambic Investment Management’s Portfolio VIVO Stock Details VIVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-53,594	Closed	-$637K	–	371
2019 Q2	$637K	Buy	+53,594	New	+$646K	0.39%	96
2019 Q1	–	Sell	-12,132	Closed	-$211K	–	410
2018 Q4	$211K	Sell	12,132 -23,700	-66%	-$404K	0.09%	252
2018 Q3	$534K	Sell	35,832 -53,643	-60%	-$832K	0.42%	85
2018 Q2	$1.42M	Sell	89,475 -71,893	-45%	-$1.07M	0.39%	92
2018 Q1	$2.29M	Buy	161,368 +32,068	+25%	+$475K	0.32%	111
2017 Q4	$1.81M	Buy	129,300 +31,600	+32%	+$463K	0.22%	161
2017 Q3	$1.4M	Buy	97,700 +42,200	+76%	+$603K	0.15%	214
2017 Q2	$874K	Buy	55,500 +20,000	+56%	+$288K	0.11%	283
2017 Q1	$490K	Buy	+35,500	New	+$496K	0.06%	411

Other funds holding VIVO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

SFM

Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Alambic Investment Management's VIVO Position: Q3 2019 in Review

Alambic Investment Management sold out of Meridian Bioscience Inc (VIVO) in Q3 2019, closing a stake of 53,594 shares — an estimated $637K sold.

Alambic Investment Management first reported a position in VIVO in Q1 2017 and held it in 9 quarters. The position peaked at $2.29M in Q1 2018. 163 funds tracked by Wall St. Rank hold VIVO as of Q3 2019.

Alambic Investment Management reported no remaining Meridian Bioscience Inc position as of Q3 2019 after selling out during the quarter.
Alambic Investment Management sold 53,594 Meridian Bioscience Inc shares in Q3 2019, an estimated $637K.
Alambic Investment Management first reported a position in Meridian Bioscience Inc in Q1 2017 and held it in 9 quarters.
Alambic Investment Management's Meridian Bioscience Inc position peaked at $2.29M in Q1 2018.
163 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q3 2019.

Based on Alambic Investment Management's 13F filing for Q3 2019, filed 12 Nov 2019.